We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Injectable Biomaterial Treats Bone Diseases

By HospiMedica staff writers
Posted on 23 Oct 2007
An injectable macro-porous material is being developed for the treatment of degenerative diseases such as osteoporosis, to refill bone cavities, and in stomatology.

Researchers at the biomaterials center of the University of Havana (BIOMAT, Cuba) are developing the injectable calcium-phosphate cement in collaboration with the biomaterials division of the Universidad Politécnica de Cataluña (Spain). More...
The cement is formed when albumen is combined with an alpha-tricalcium phosphate paste, which hydrolyzes to a calcium deficient hydroxyapatite during the setting reaction. The resulting cement is easy to manipulate, possesses fast compression, and has flexible properties similar to other known macro-porous materials. The mineral composition of the compound is very similar to bone and as a result is very useful for tissue engineering, disseminating the cells of the patient in the material for subsequent implantation.

"One of the main difficulties of medicine at present is the considerable increase of the pathologies related to bone problems,” said Dr. Amisel Almirall, Ph.D., the researcher at BIOMAT in charge of the project. "Half the chronic diseases suffered by people over 65 are related to articulation deficiencies; in addition, the number of bone fractures caused by osteoporosis and traffic accidents has doubled in the last ten years.”

One example of a potential use of the cement is in filling bone voids after maxillary cyst removal, preventing loose teeth due to the rapid reconstitution of the bone.


Related Links:
Universidad Politécnica de Cataluña
University of Havana

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.